SIVELLI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 1.060
EU - Europa 771
AS - Asia 236
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.070
Nazione #
US - Stati Uniti d'America 1.055
IT - Italia 302
UA - Ucraina 158
TR - Turchia 119
SE - Svezia 101
DE - Germania 75
CN - Cina 59
VN - Vietnam 46
FI - Finlandia 41
IE - Irlanda 40
BE - Belgio 18
FR - Francia 11
GB - Regno Unito 10
JP - Giappone 9
RU - Federazione Russa 7
CZ - Repubblica Ceca 4
MX - Messico 4
CL - Cile 2
AT - Austria 1
CA - Canada 1
EU - Europa 1
HU - Ungheria 1
ID - Indonesia 1
IN - India 1
NL - Olanda 1
RS - Serbia 1
SG - Singapore 1
Totale 2.070
Città #
Chandler 201
Milan 198
Jacksonville 123
Woodbridge 86
Houston 78
Ann Arbor 70
Fairfield 67
Izmir 64
Nyköping 61
Dearborn 45
Wilmington 43
Princeton 42
Ashburn 40
Dublin 40
Dong Ket 28
Seattle 23
Boardman 21
San Mateo 20
Rome 19
Cambridge 15
San Diego 13
Beijing 12
Brussels 12
New York 9
Ogden 9
Kunming 8
Tokyo 8
Nanjing 6
Como 5
Düsseldorf 5
Berlin 4
Brno 4
Cagliari 4
Cuauhtémoc 4
Falls Church 4
Frankfurt am Main 4
Hangzhou 3
Munich 3
Calvisano 2
Changsha 2
Dalmine 2
Guangzhou 2
Hebei 2
Hefei 2
London 2
Nanchang 2
Redmond 2
Shenyang 2
Washington 2
Albano Laziale 1
Belgrade 1
Bisaccia 1
Borås 1
Budapest 1
Chicago 1
Chongqing 1
Codogno 1
Genova 1
Harbin 1
Helsinki 1
Huzhou 1
Jinan 1
Legnano 1
Los Angeles 1
Modena 1
Motta Visconti 1
Mountain View 1
Nanning 1
Norwalk 1
Pune 1
Shanghai 1
Singapore 1
Taiyuan 1
Tappahannock 1
Terracina 1
Toronto 1
Vienna 1
Villanterio 1
Wenzhou 1
Zhengzhou 1
Totale 1.454
Nome #
Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO 158
Consensus Statement of the European Group on Graves' Orbitopathy (EUGOGO) on Management of Graves' Orbitopathy 153
Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent Graves' orbitopathy: a retrospective cohort study 148
MP-1 Nidek vs. Spectral OCT/SLO OTI Microperimeter on the Evaluation of Retinal Sensibility in Different Macular Diseases 126
New Instruments Kit For Amniotic Membrane Transplant With Fibrin Glue. 125
A New Surgical Method for Sterile Corneal Ulceration 107
Oftalmologia Clinica 107
Intraocular Pressure at High Altitude 97
GDxVCC Polarimetry vs a New Optical Tomograph OCT/SLO on Retinal Nerve Fiber Thickness Evaluation in Early Glaucoma 93
Effects of Intravitreal Antiangiogenic Drugs on Ocular Blood Flow Parameters by Color Doppler Imaging 91
Fundus autofluorescence evaluation in exudative macular degeneration after intravitreal bevacizumab treatment 90
Intraocular Pressure at High Altitude 88
New Combined 23-20 Gauge Vitreoretinal Surgery 88
Retinal Morphology and Retinal Nerve Fibres Layer Changes After Intravitreal Ranibizumab for Exudative AMD: Nine Months-Prospective Study 82
Combined treatment with Anti-Vegf and Perforating Keratoplasty in Neovascularized Corneas 79
Evaluation of Retinal Morphology and Retinal Sensibility Before and After Macular Pucker Surgery 79
Intravitreal Bevacizumab Alone vs Laser Combined Treatment for Macular Edema Secondary to Branch Retinal Vein Occlusion 76
Bevacizumab Versus Ranibizumab For Age Related Macular Degeneration: 1-year Outcomes Of An Interventional Study 75
Il trattamento delle ulcere neurotrofiche con tecnica SLAM. 74
Photorefractive Keratectomy Using an Excimer Laser For Post-Penetrating Keratoplasty Elevated Astigmatism 66
RNFL Study in Graves Orbitopathy 54
UN CASO DI ORBITOPATIA BASEDOWIANA GRAVISSIMA AD ESORDIO IMPROVVISO CON OTTIMA RISPOSTA ALLA TERAPIA MEDICA. 16
Totale 2.072
Categoria #
all - tutte 6.625
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.625


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020262 6 6 9 37 7 32 61 35 13 27 4 25
2020/2021224 4 28 0 30 0 23 3 21 51 2 23 39
2021/2022231 14 29 20 22 17 6 9 18 13 34 11 38
2022/2023421 31 46 38 66 29 90 2 43 51 9 5 11
2023/2024396 63 50 51 83 65 24 0 12 14 5 3 26
2024/202511 11 0 0 0 0 0 0 0 0 0 0 0
Totale 2.072